A research team from the Institute of Medical Microbiology, University of Münster, Germany, has developed a method that accelerates resistance testing. In cooperation with an industrial partner, this innovative method can now be optimized for the diagnostic market.
Respiratory, urinary tract, wound infections, and sepsis: the list of sites in which severe and life-threatening diseases manifest as a result of multidrug resistant microorganisms is long. The best option is an antibiotic treatment targeted specifically to the detected pathogen. However, the identification of microorganisms and their resistances to antibiotics is time consuming.
Symbolic picture: Application of microdroplets for rapid determination of resistance using MALDI-TOF mass spectrometry
photo: FZ / E. Deiters-Keul
A research team from the Institute of Medical Microbiology, University of Münster, Germany, has developed a method that considerably accelerates resistance testing. Supported by the German Federal Ministry of Education and Research (BMBF), and in cooperation with an industrial partner, the research team is currently developing this method. Soon to be on the market, it will be readily available for patient management.
The novel method proposed by project leaders Evgeny A. Idelevich, M.D. and Karsten Becker, M.D. is based on MALDI-TOF mass spectrometry, which was recently introduced for microbial identification. Prof. Becker observed, “We also need new techniques for more expedient detection of acquired antibiotic resistance”.
Currently applied methods require more than 24 hours, as they are dependent on bacterial growth. The innovative method from Münster would allow earlier optimization of patient treatment and the prompt initiation of infection control measures, crucial for the protection of hospital patients from a spread of multidrug resistant bacteria.
Currently, many physicians administer broad-spectrum antibiotics to swiftly provide a reliable medicine. Unfortunately, microorganisms can become resistant due to this very treatment. The shift to a more targeted antibiotic therapy reduces antibiotic selection pressure and thus, the emergence of multiresistant bacteria.
Dr. Idelevich added, “The application of MALDI-TOF mass spectrometry for resistance testing was attractive to our research due to its expediency and high accuracy. It can also be optimally combined with the identification process, rendering it cost-efficient”.
Based on this technology, both researchers have developed a rapid and universal method for resistance determination which is independent from the underlying resistance mechanisms and can be performed simultaneously for multiple antibiotics. Through the license agreement with Bruker Daltonik (Bremen, Germany), a pioneer in mass spectrometry technologies, this innovative method can now be developed further and optimized for the diagnostic market.
Prof. Becker commented, “We hope that our method will be available for routine use in clinical laboratories in 2-3 years”. Here in Münster, we are particularly proud of the MALDI-TOF mass spectrometry project, as the MALDI-TOF technology was greatly influenced in the 1980s by Münster scientists. At that time, the groundwork was established for today’s microbial identification. Currently, thousands of laboratories worldwide already use a MALDI-TOF instrument. This sets optimal preconditions for the wide-spread and cost-efficient implementation of our method.”
The cooperation between academic and industrial institutions in Münster and Bremen will be supported by the BMBF for an additional three years; a grant totaling more than 900,000 Euros was awarded to the academic and industrial partners.
Dr. Thomas Bauer
Referent Research and Teaching at Münster University Medical Faculty
Dr. Thomas Bauer | idw - Informationsdienst Wissenschaft
Building blocks for new medications: the University of Graz is seeking a technology partner
19.03.2019 | Karl-Franzens-Universität Graz
Scientists find new approach that shows promise for treating cystic fibrosis
14.03.2019 | NIH/National Heart, Lung and Blood Institute
Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have proposed a way to create a completely new source of radiation. Ultra-intense light pulses consist of the motion of a single wave and can be described as a tsunami of light. The strong wave can be used to study interactions between matter and light in a unique way. Their research is now published in the scientific journal Physical Review Letters.
"This source of radiation lets us look at reality through a new angle - it is like twisting a mirror and discovering something completely different," says...
New research group at the University of Jena combines theory and experiment to demonstrate for the first time certain physical processes in a quantum vacuum
For most people, a vacuum is an empty space. Quantum physics, on the other hand, assumes that even in this lowest-energy state, particles and antiparticles...
Physicists in the EPic Lab at University of Sussex make crucial development in global race to develop a portable atomic clock
Scientists in the Emergent Photonics Lab (EPic Lab) at the University of Sussex have made a breakthrough to a crucial element of an atomic clock - devices...
Every year earthquakes worldwide claim hundreds or even thousands of lives. Forewarning allows people to head for safety and a matter of seconds could spell...
Scientists of the Department of Physics at the University of Hamburg, Germany, detected the magnetic states of atoms on a surface using only heat. The...
11.03.2019 | Event News
01.03.2019 | Event News
28.02.2019 | Event News
19.03.2019 | Physics and Astronomy
19.03.2019 | Life Sciences
19.03.2019 | Materials Sciences